Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations.
J. Viral Hepat., Apr;19(4):236-43 (2012)
Multivisceral ex vivo surgery for tumors involving celiac and superior mesenteric arteries.
Am. J. Transplant., May;12(5):1323-8 (2012)
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study.
Aliment. Pharmacol. Ther., Oct;34(8):853-61 (2011)
Evaluation of blood glucose levels after hepatitis B immune globulin administration utilizing two different blood glucose monitoring systems.
Transplant. Proc., Dec;42(10):4123-6 (2010)
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry.
Am. J. Transplant., Jul;10(7):1621-33 (2010)
Analysis of monomeric and dimeric phosphorylated forms of protein kinase R.
Biochemistry., Feb;49(6):1217-25 (2010)
Hypothermic machine preservation in human liver transplantation: the first clinical series.
Am. J. Transplant., Feb;10(2):372-81 (2010)
The impact of hepatitis C and biliary complications on patient and graft survival following liver transplantation.
Am. J. Transplant., Jun;9(6):1398-405 (2009)
Resource utilization of living donor versus deceased donor liver transplantation is similar at an experienced transplant center.
Am. J. Transplant., Mar;9(3):586-91 (2009)
The evolution and direction of OPTN oversight of live organ donation and transplantation in the United States.
Am. J. Transplant., Jan;9(1):31-4 (2009)
Review article: a pharmacoeconomic analysis of thrombocytopenia in chronic liver disease.
Aliment. Pharmacol. Ther., Nov;26 Suppl 1:41-8 (2007)
The case: a pregnant woman with hyponatremia.
Kidney Int., Nov;72(9):1167-9 (2007)
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
Am. J. Transplant., Jun;7(6):1601-8 (2007)
Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9.
J. Mol. Biol., Feb;366(2):563-73 (2007)
Hepatitis B treatment: Lessons for the nephrologist.
Kidney Int., Dec;70(11):1897-904 (2006)